CN Healthy Food Tech Group Corp. (UCFI) - Annual Investor Guide

I’ve put together this guide to help you understand how CN Healthy Food Tech Group Corp. performed this year. My goal is to cut through the corporate jargon so you can decide if this company fits your investment goals.

1. What does this company do?

CN Healthy Food Tech Group Corp. (UCFI) is a Chinese wellness brand that blends traditional ingredients—like ginseng and cordyceps—with modern biotechnology. They sell nutritional powders, snacks, and health beverages through 10,000 retail points and major e-commerce platforms like JD.com.

The company uses a "tech-first" approach, utilizing AI-powered digital avatars for 24/7 live-stream sales and data tools to track customer trends and manage inventory in real-time.

2. Major wins and challenges this year

The company merged with Iron Horse Acquisition Corp. and began trading on the Nasdaq as UCFI on October 1, 2025, at a $450 million valuation.

Currently, the stock is under a trading halt. The China Securities Regulatory Commission (CSRC) is reviewing the company’s U.S. listing. Until they receive official approval, the stock remains frozen, meaning you cannot buy or sell shares during this time.

Operationally, they are expanding. They opened an 18,000-square-meter automated factory in Daqing, which focuses on high-profit extracts and already generates 13% of their $112 million annual revenue. Additionally, they have earmarked $15 million to launch 50 "Traditional Chinese Medicine" health centers in 2025.

3. Key risks for investors

• The Trading Halt: This is the most urgent risk. Because the stock is frozen, your capital is currently illiquid. If the company fails to meet CSRC requirements, it could be forced off the Nasdaq and onto "Over-the-Counter" markets, where trading volume and liquidity are significantly lower.
• Regulatory Pressure: As a Chinese company, they must navigate both U.S. audit standards and Chinese data laws. Conflicts between these regulatory environments could lead to fines or forced delisting from U.S. exchanges.
• Limited History: The company restructured in early 2024, and the merger was only finalized in late 2025. This short track record makes it difficult to gauge the long-term sustainability of their aggressive spending on AI-influencers and physical infrastructure.

4. Financial health

The company reported $112 million in annual revenue with a 38% profit margin. While they hold 13 patents and 85 trademarks, these are intangible assets. Their AI strategy has successfully reduced marketing costs by 12%. However, the new Daqing factory carries high operational costs, and the planned $8 million investment in physical clinics will further impact cash flow. We are monitoring their debt levels closely to ensure they maintain a healthy balance sheet during this expansion phase.

What’s next? I am watching their regulatory filings closely. We need to see if their new factory and AI tools translate into sustained profit growth, or if the high costs of this expansion will continue to pressure their margins. Until the trading halt is lifted and the company provides more clarity on its operational costs, this remains a "wait and see" situation.